Crown Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CROWN LABS
CROWN LABS has six approved drugs.
Drugs and US Patents for Crown Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crown Labs Inc | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 207730-001 | Dec 26, 2017 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Crown Labs | ALA-CORT | hydrocortisone | CREAM;TOPICAL | 080706-006 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Crown Labs | TRIDERM | triamcinolone acetonide | CREAM;TOPICAL | 088042-001 | Mar 19, 1984 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

